Keeping COVID-19 at Bay $58.096M Market Capitalization Draganfly Inc. (DPRO.C), an award-winning, industry-leading drone solutions and system developer, announced today that the Company’s Vital Intelligence Smart Vital Kiosks (“Smart…
infectious disease
Latest News Revive Therapeutics Ltd. (RVV.C) has provided an update for the Company’s U.S. Food and Drug Administration (FDA) Phase 3 clinical trial to evaluate the safety and efficacy…
XPhyto Therapeutics (XPHY.C), with its partner and acquisition target, 3a-diagnostics GmbH announced today that it has successfully registered its first biosensor test in oral inflammation with the German authorities….
Predictmedix (PMED.C) recent partnership with India’s Tier 2 defence engineering company, Para Defence and Space Technologies, intends to target the government and public sector market in South Asia, according…
Revive Therapeutics (RVV.C) intends to advance its product pipeline to human clinical studies in regions where its products have already acquired regulatory approval and are approved for sale. The…